Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Beem Biologics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Beem Biologics

Beem Biologics

Beem Biologics manufactures agricultural biologicals for enhanced crop health, pest control, and sustainable farming.

HQ
Maricopa, AZ, US
Founded
2015
Overview
Compare
Fundraising
Employees

Beem Biologics focuses on discovering, developing, and manufacturing agricultural biological chemicals to enhance crop health, increase yields, and provide sustainable farming solutions. Their products, including ISOPLEX, are designed to repel pests and reduce risks for farmers, golf course managers, and homeowners. The company aims to revolutionize the agricultural chemical industry with innovative biopesticides and biostimulants.

Beem Biologics has achieved significant milestones, including licensing ISOPLEX to Arysta LifeScience, a major player in the agricultural chemical industry. This partnership highlights the company's impact on sustainable farming practices and its role in advancing agricultural technology.

Beem Biologics - Similar Companies

Biodel logo

Biodel

biodelag.com

Beemmunity logo

Beemmunity

Phyllom BioProducts logo

Phyllom BioProducts

Agrynex logo

Agrynex

agrynex.us

Advanced Biological Marketing logo

Advanced Biological Marketing

AgBiome logo

AgBiome

agbiome.com

AgriMetis logo

AgriMetis

Biowish Technologies logo

Biowish Technologies

Lepidext logo

Lepidext

lepidext.com

3Bar Biologics logo

3Bar Biologics

3barbiologics.com

ZestBio logo

ZestBio

zestbio.com

iQBiotech logo

iQBiotech

Beagle Bioproducts logo

Beagle Bioproducts

Gaais logo

Gaais

Boragen logo

Boragen

Beem Biologics - Quick Facts

Who are Beem Biologics' competitors?

Companies similar to Beem Biologics include Biodel, Beemmunity, Phyllom BioProducts and Agrynex.

When was Beem Biologics founded?

Beem Biologics was founded in 2015.

Where is Beem Biologics' headquarters located?

Beem Biologics' headquarters is located in Maricopa, AZ, US.

When was Beem Biologics' last funding round?

Beem Biologics' most recent funding round was for $494.2k (USD) in July 2015.

How much has Beem Biologics raised to-date?

As of Jul 15, 2015, Beem Biologics has raised a total of $569.2k (USD).

How many employees does Beem Biologics have?

Beem Biologics has 20 employees as of Feb 4, 2024.

Beem Biologics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Agricultural Biologicals
Tags
  • AgTech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2800Chemicals And Allied Products
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 7 more industry codes
NAICS
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 2830Drugs